Screening for Albuminuria in Patients with Diabetes

Downloads
Revenue

Description

A quick pocket tool to help medical professionals assess and treat albuminuria in people with diabetes and other high risk patients. Designed for rapid, convenient, point-of-care intervention whenever and wherever you need it. Content is adapted from KDOQI evidence-based clinical practice guidelines and recommendations from the National Kidney Foundation.
Features:
Designed for rapid, convenient, point-of-care intervention. With a few quick taps, you will:
•Evaluate diabetic patients for albuminuria and chronic kidney disease (CKD)
•Use evidence-based strategies to assess and treat
•Access an interactive, clinical action plan that can be individualized for your patients
Simple, quick, and organized by:
•What is Albuminuria?
•Why screen for albuminuria in high risk patients?
•When to screen
•How to screen
•Follow-up using a simple, interactive decision-making algorithm
•Facts about albuminuria, diabetes, and chronic kidney disease
Facts About Chronic Kidney Disease
•Kidney disease is common, harmful, and treatable.
•26 million Americans have kidney disease – but most do not know they have it. Millions more are at increased risk.
•High risk groups include those with diabetes, hypertension, and a family history of kidney disease. Blacks, Hispanics, Asians, Pacific Islanders, American Indians, and seniors are also at increased risk.
•Early detection can slow the progression of kidney disease.
•Once kidneys fail, patients need dialysis or a transplant to survive.
The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention, and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions of patients and their families, and tens of millions of Americans at risk.
By supporting the National Kidney Foundation, you directly influence and positively impact the lives of those at risk for kidney disease, those living with chronic kidney disease, and those who care for and about them.
Learn more at www.kidney.org
30 East 33rd Street
New York, NY 10016
www.kidney.org
800-622-9010
Hide Show More...

Screenshots

Screening for Albuminuria in Patients with Diabetes FAQ

  • Is Screening for Albuminuria in Patients with Diabetes free?

    Yes, Screening for Albuminuria in Patients with Diabetes is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Screening for Albuminuria in Patients with Diabetes legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Screening for Albuminuria in Patients with Diabetes cost?

    Screening for Albuminuria in Patients with Diabetes is free.

  • What is Screening for Albuminuria in Patients with Diabetes revenue?

    To get estimated revenue of Screening for Albuminuria in Patients with Diabetes app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Türkiye yet.
Ratings History

Screening for Albuminuria in Patients with Diabetes Reviews

No Reviews in Türkiye
App doesn't have any reviews in Türkiye yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
488

Screening for Albuminuria in Patients with Diabetes Installs

Last 30 days

Screening for Albuminuria in Patients with Diabetes Revenue

Last 30 days

Screening for Albuminuria in Patients with Diabetes Revenue and Downloads

Gain valuable insights into Screening for Albuminuria in Patients with Diabetes performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.